我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
11
3 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1847
进行中（未招募）
2
18.2%
已完成
3
27.3%
Enrolling By Invitation
1
9.1%
招募中
终止
撤回
暂无批准数据
- Rochester General Hospital is the first U.S. site to initiate a pivotal clinical trial of AquaPass, a novel system for fluid overload in heart failure patients. - The AquaPass system, a non-invasive suit, uses warm air to remove excess fluid through the skin, offering a renal-independent, drug-free approach. - Clinical trials in Israel demonstrated weight reduction, decreased diuretic use, improved quality of life, and reduced hospital readmissions with AquaPass. - The ongoing trial at Rochester General Hospital aims to secure FDA approval for AquaPass, potentially providing a cost-effective, at-home treatment option.
